Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-01-08

Clinical Trial Update: Ketamine for the Treatment for Alcohol Use Disorder in the ED [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating ketamine for alcohol use disorder in the emergency department has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Alcohol Use Disorder | Phase 2 | Status: WITHDRAWN